Drug Profile
Research programme: modafinil/opioid analgesic combinations: Victory Pharma
Alternative Names: MGX-002Latest Information Update: 21 Aug 2019
Price :
$50
*
At a glance
- Originator BTG
- Developer Victory Pharma
- Class
- Mechanism of Action Alpha 1 adrenergic receptor agonists; Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 19 Aug 2019 BTG has been acquired by Boston Scientific Corporation
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in USA
- 13 Jun 2007 Preclinical trials in Pain in USA (unspecified route)